|
|
News Breaks | | | | September 7, 2012 | | 08:08 EDT |  | NEPT | Neptune reports dividend-in-kind, partial NeuroBioPharm spin-off record date
Neptune Technologies & Bioressources announced that its board of directors has approved the distribution of 2M units of NeuroBioPharm Inc. owned by Neptune pro rata to the holders of record of common shares of Neptune as of Oct. 15, 2012 by way of a dividend-in-kind. The Dividend will be payable on Oct. 31, 2012. | |
|
News For NEPT From The Last 14 Days Check below for free stories on NEPT the last two weeks. |
|
|
| May 15, 2013 | | 08:44 EDT | | NEPT | Neptune responds to Aker's attempts to deflect attention from patent dispute
Neptune Technologies & Bioressources announces that the United States Patent and Trademark Office recently issued a NON-FINAL Action Closing Prosecution in a re-examination of Neptune's Patent No. 8,030,348. Aker BioMarine, in yet another clear attempt to shift focus from its ongoing infringement of multiple Neptune patents, issued a press release addressing the re-examination. However Aker neglected to disclose that the USPTO's decision to reject Neptune's claims regarding composition of matter was only one procedural step in the long process of re-examination. Neptune will have the opportunity to submit additional arguments stating its position before the USPTO renders a final decision. | | | 08:20 EDT | | NEPT | Class action against Neptune Technologies dismissed
Neptune Technologies & Bioressources announces that the previously announced class action lawsuit filed against Neptune and certain of its officers on December 19, 2012 by Robbins Geller Rudman & Dowd LLP in the United States District Court for the Southern District of New York was voluntarily dismissed by the plaintiffs, without prejudice. No payment was made by any of the defendants in connection with the dismissal. | |
|
|
|
|
|
|
